CARMA1 Blocking Peptide
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Product Concentration 0.2 mg/ml Amino Acid Location 14 amino acids at the C-terminus of the human CARMA1 protein. Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Storage and Handling Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient Amino Acid Sequence 14 amino acids at the carboxy terminus of the human CARMA1 protein. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionBackground CARMA1 peptide is applicable as a control peptide for blocking antibody binding in Western blotting. References & Citations1. Gaide O, Martinon F, Michau O, et al. Carma1, 1 CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappa B activation. FEBS Lett.2001; 496:121-7.
2. Bertin J, Wang L, Guo Y, et al. CARD11 and CARD14 are novel caspase
recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family
members that interact with BCL10 and activate NF-kappa B. J. Biol. Chem. 2001;
276:11877-82. |
Related Products
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
